Art

J-GLOBAL ID：201902241275756804   Reference number：19A0782015

Prediction of treatment responses to neoadjuvant chemotherapy in triple-negative breast cancer by analysis of immune checkpoint protein expression

免疫チェックポイント蛋白質発現の分析によるトリプルネガティブ乳癌におけるネオアジュバント化学療法に対する治療反応の予測【JST・京大機械翻訳】

Author (12)： Asano Yuka (Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan) ,  Kashiwagi Shinichiro (Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan) ,  Goto Wataru (Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan) ,  Takada Koji (Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan) ,  Takahashi Katsuyuki (Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka, Japan) ,  Morisaki Tamami (Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan) ,  Fujita Hisakazu (Department of Scientific and Linguistic Fundamentals of Nursing, Osaka City University Graduate School of Nursing, Osaka, Japan) ,  Takashima Tsutomu (Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan) ,  Tomita Shuhei (Department of Pharmacology, Osaka City University Graduate School of Medicine, Osaka, Japan) ,  Ohsawa Masahiko (Department of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan) ,  Hirakawa Kosei (Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan) ,  Ohira Masaichi (Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan)
Material： Journal of Translational Medicine (Web)
Volume： 16  Issue： 1  Page： 87  Publication year： 2018 
JST Material Number： U7330A  ISSN： 1479-5876  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： “Avoiding immune destruction” ...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A0782015&from=J-GLOBAL&jstjournalNo=U7330A") }}

Thesaurus term： *breast tumor ,  tumor cell ,  biomarker ,  *protein ,  multivariate analysis ,  human(primates) ,  immunohistochemistry ,  *drug therapy ,  EGF receptor
Semi thesaurus term： 予後因子 ,  無病生存 ,  単変量解析 ,  CD274抗原 ,  プログラム細胞死1受容体 ,  *蛋白質発現 , 【Automatic Indexing@JST】

Author keywords (6)： Immune checkpoint ,  Triple-negative breast cancer ,  Pathological complete response ,  Neoadjuvant chemotherapy ,  PD-1 ,  PD-L1

JST classification (1)： Chemistry,biochemistry and pathology of tumors(=neoplasms)  (GE02030N)

Reference (42)：

• Science; Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion; RD Schreiber, LJ Old, MJ Smyth; 331; 6024; 2011; 1565-1570; 10.1126/science.1203486; citation_id=CR1
• Science; Breakthrough of the year 2013, Cancer immunotherapy; J Couzin-Frankel; 342; 6165; 2013; 1432-1433; 10.1126/science.342.6165.1432; citation_id=CR2
• Nat Rev Immunol; Molecular mechanisms of T cell co-stimulation and co-inhibition; L Chen, DB Flies; 13; 4; 2013; 227-242; 10.1038/nri3405; citation_id=CR3
• Proc Natl Acad Sci USA; Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade; Y Iwai, M Ishida, Y Tanaka, T Okazaki, T Honjo, N Minato; 99; 19; 2002; 12293-12297; 10.1073/pnas.192461099; citation_id=CR4
• N Engl J Med; Nivolumab in previously untreated melanoma without BRAF mutation; C Robert, GV Long, B Brady, C Dutriaux, M Maio, L Mortier, JC Hassel, P Rutkowski, C McNeil, E Kalinka-Warzocha; 372; 4; 2015; 320-330; 10.1056/NEJMoa1412082; citation_id=CR5

Terms in the title (8)： 免疫 ,  チェックポイント ,  蛋白質発現 ,  分析 ,  トリプルネガティブ乳癌 ,  ネオアジュバント化学療法 ,  治療反応 ,  予測